Vaccines

Jun 25, 2015
By Pharmaceutical Technology Editors
The divestment of Nimenrix and Mencevax was to satisfy regulatory clearances when GSK gained Novartis’ vaccines business in an asset swap in March 2015.
May 21, 2015
By Pharmaceutical Technology Editors
Medicago's new production facility will make plant-based vaccines and therapeutics.
May 11, 2015
By Pharmaceutical Technology Editors
A vaccine patch may eliminate the need for traditional means of vaccine distribution, according to an article in NPR.
Apr 27, 2015
By Pharmaceutical Technology Editors
Catalent’s Zydis technology will be used to develop thermo-stable and cold-chain independent vaccines.
Apr 20, 2015
By Pharmaceutical Technology Editors
GSK notifies CDC and FDA that it is recalling the remaining doses of its 2014–2015 flu vaccine, Flulaval Quadrivalent Thimerosal-free Pre-Filled Syringes, due to decreased potency.
Apr 03, 2015
By Pharmaceutical Technology Editors
GlaxoSmithKline announces global vaccines research and design facility to be based in Rockville, MD, USA.
Apr 02, 2015
By Pharmaceutical Technology Editors
NIH announced positive safety results from the vaccine, VSV-ZEBOV, and found that all patients in the study experienced a strong antibody response.
Mar 26, 2015
FDA has approved another indication for Eylea, a treatment for diabetic retinopathy in patients with diabetic macular edema.
Mar 25, 2015
By Pharmaceutical Technology Editors
Emergent BioSolutions announced FDA approval of Anthrasil, an inhalable treatment that targets Anthrax toxins, as well as a contract with BARDA to develop NuThrax, an anthrax vaccine candidate.
Mar 24, 2015
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The agency provides guidance on determining the need for environmental assessments for gene therapies, vectored vaccines, and viral and microbial products.
native1_300x100
lorem ipsum